In the News

The Situation: This global pharmaceutical company had grown steadily over many decades through many acquisitions. For much of that period, technology management was decentralized allowing each business unit and site to invest independently. Over time, this led to a significant duplication of systems and processes with inconsistent data. As executive leadership called for more capabilities to leverage research and development efforts globally, it became clear that the technology strategy needed to change.